1. Home
  2. HUT vs ALKS Comparison

HUT vs ALKS Comparison

Compare HUT & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hut 8 Corp.

HUT

Hut 8 Corp.

HOLD

Current Price

$43.88

Market Cap

4.2B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$28.53

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUT
ALKS
Founded
2011
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.6B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
HUT
ALKS
Price
$43.88
$28.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
13
Target Price
$51.08
$42.85
AVG Volume (30 Days)
7.1M
1.9M
Earning Date
11-04-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.44
EPS
1.89
2.02
Revenue
$178,318,000.00
$1,521,338,000.00
Revenue This Year
$74.79
N/A
Revenue Next Year
$116.78
$24.22
P/E Ratio
$23.55
$14.14
Revenue Growth
5.60
1.08
52 Week Low
$10.04
$25.17
52 Week High
$57.29
$36.45

Technical Indicators

Market Signals
Indicator
HUT
ALKS
Relative Strength Index (RSI) 53.58 46.34
Support Level $38.36 $27.69
Resistance Level $45.64 $28.53
Average True Range (ATR) 4.49 0.85
MACD -0.04 -0.03
Stochastic Oscillator 74.71 42.22

Price Performance

Historical Comparison
HUT
ALKS

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: